Bandingkan Harga & Kinerja Bank OCBC NISP Tbk. (NISP) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank OCBC NISP Tbk. dan Organon Pharma Indonesia Tbk.: Bank OCBC NISP Tbk. diperdagangkan di Rp1.265 (kapitalisasi pasar 29,08 T, volume 24 jam 6 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bank OCBC NISP Tbk. jauh lebih besar — sekitar 278,5× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| NISP | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 29,08 T | 104,4 M |
Volume | 6 jt | — |
Lot | 60 rb | — |
Perputaran | 7,6 M | — |
Harga Rata-rata | 1.267,4 | — |
Nilai Transaksi | 7,6 M | — |
Harga Ekuilibrium Indikatif | 1.265 | — |
Volume Ekuilibrium Indikatif | 5,23 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank OCBC NISP Tbk.
PT Bank OCBC NISP Tbk, formerly PT Bank NISP Tbk. Bank NISP was established in 1941 based on deed No. 6 dated April 4, 1941 of notary Theodoor Johan Indewey Gerlings, under the name NV. Nederlandsch Indische Spaar En Deposito Bank (NISP). On May 1995 the bank has raised a US$ 19 million loan, to finance its expanding export credits. On 22 September 2010, the Board of Commissioners and Directors of Bank OCBC NISP and PT Bank OCBC Indonesia (Bank OCBC Indonesia) approved the merger plan related to the merger of Bank OCBC Indonesia into Bank OCBC NISP where Bank OCBC NISP will become the surviving Bank. The effective date of the merger of the Bank with PT Bank OCBC Indonesia was determined on 1 January 2011 based on Notarial Deed No. 10 dated 9 November 2010 of Fathiah Helmi, SH., notary in Jakarta.
Selengkapnya di halaman NISP →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
